Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Retinoblastoma is a rare childhood cancer of the eye. It arises from the retina, the nerve tissue in the back of the eye that is sensitive to light. Thanks to advances in diagnosis and treatment, more than 95% of children with retinoblastoma can now be cured.
Children with retinoblastoma are treated through the
Retinoblastoma Program at Dana-Farber/Boston Children's Cancer and Blood Disorders Center. We offer the full range of multidisciplinary treatment options for retinoblastoma, including intra-arterial chemotherapy – a recently-developed treatment option that often can provide the most effective retinoblastoma treatment with the fewest side effects.
in-depth information on retinoblastoma on the Dana-Farber/Boston Children's website, including answers to:
Appointments and Second Opinions